This inventor holds 1 USPTO granted patent. Top assignee: Dk Holdings Company, Ltd. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Eun-Jeong Yoon: Innovator in Antibiotic Resistance Detection
Introduction
Eun-Jeong Yoon is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of microbiology, particularly in the detection of antibiotic resistance. Her innovative approach has the potential to revolutionize how we identify resistant microorganisms in clinical settings.
Latest Patents
Eun-Jeong Yoon holds a patent for her invention titled "Direct detection of the active form of beta-lactam-hydrolysing enzymes by using mass spectrophotometry." This invention relates to a method for directly detecting whether a microorganism in a sample is resistant to antibiotics. The method utilizes mass spectrometry to identify antibiotic hydrolases secreted by resistant microorganisms. This allows for a rapid and straightforward confirmation of antibiotic resistance, significantly reducing the time required for diagnosis from several days to just a few minutes.
Career Highlights
Eun-Jeong Yoon is currently associated with Dk Holdings Company, Ltd., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving diagnostic methods in microbiology, particularly in the context of antibiotic resistance.
Collaborations
Eun-Jeong Yoon collaborates with notable colleagues, including Kye Shin Park and Joon Sang Park. These partnerships enhance her research capabilities and contribute to the development of innovative solutions in the field.
Conclusion
Eun-Jeong Yoon's contributions to the detection of antibiotic resistance exemplify the importance of innovation in healthcare. Her work not only addresses a critical issue in modern medicine but also paves the way for faster and more efficient diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile